However, he did not go into the details of the possible restructuring. According to Saunders, there is overlap between the two companies in areas such as human resources and finance.
FTA Online News
25/11/2014 International Stock Exchanges – ECONOMY THE PRESS
Actavis is preparing to reduce its workforce and expand business in China, according to as declared by the chief executive Brent Saunders to Bloomberg Television. The generics maker, which has reached an agreement to take over Allergan, the maker of Botox, in a $66 billion deal, has not, however, gone into details of the possible restructuring. According to Saunders, there is overlap between the two companies in areas such as human resources and finance.
(RR)
